RICHMOND, Va. and HYDERABAD, India, Aug. 3, 2011 /PRNewswire/ —
Emerging and re-emerging infectious diseases, such as tuberculosis
and malaria, have long been of national concern in India, a trend
that continues today. Arguably, one of the best means of
preparedness to deal with current and future disease outbreaks is
the fortification of public health, research and drug manufacturing
capabilities. India’s awareness and growing economic status allow
for such preparedness to fend off the next public health incident,
part of which should be focused on increasing India’s health and
research infrastructure and capacity.
A major component of public health and research infrastructure
necessary to evaluate and respond to these epidemic diseases is
biocontainment laboratories. Various public, academic and private
institutions in India operate biocontainment, or biosafety, labs,
such as BSL2, BSL3 and BSL4. Further, many existing
facilities in India can be upgraded quickly and cost-effectively to
achieve higher biosafety standards. India boasts some of the
highest-quality biomedical laboratory facilities in the world, and
is known for being an international hotbed of biopharmaceutical
production. With the imminent rise of infectious diseases in India
and abroad, research, health and manufacturing facilities necessary
to combat these plagues will reach new levels of demand.
Recently, a new partnership between Integrated Cleanroom
Technologies Ltd. (ICLEAN; Hyderabad, India) and Alliance
Biosciences (U.S.) has been developed to support the increasing
demand for research and health biosafety laboratories. The result
of this partnership is a unique blend of biosafety and engineering
expertise, married with ICLEAN’s capabilities of diverse laboratory
design and construction. Alliance Biosciences, known
internationally for their design and consultation surrounding
high-containment biological research, clinical and diagnostic
faci
‘/>”/>
